# China NMPA Drug Inspection - Wujiang Shanghai Cai Tongde Traditional Chinese Medicine Pieces Co., Ltd. - North American ginseng

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/wujiang-shanghai-cai-tongde-traditional-chinese-medicine-pieces-co-ltd/f2b45c99-a30b-4a20-bca0-f92d8b1dd8fe/
Source feed: China

> China NMPA drug inspection for Wujiang Shanghai Cai Tongde Traditional Chinese Medicine Pieces Co., Ltd. published November 24, 2017. Drug: North American ginseng. The Shanghai Municipal Food and Drug Administration (SMFDA) issued its 2017 Issue 7 Drug Supervision and Sampling Qualit

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Shanghai Municipal Food and Drug Administration's 7th Announcement on Drug Supervision and Sampling Quality in 2017 (November 24, 2017)
- Company Name: Wujiang Shanghai Cai Tongde Traditional Chinese Medicine Pieces Co., Ltd.
- Publication Date: 2017-11-24
- Drug Name: North American ginseng
- Inspection Finding: Properties and processing
- Action Taken: Suspend sales and use, recall products and rectify issues; strengthen follow-up inspections and daily supervision, urge enterprises to investigate the causes and implement corrective measures.
- Summary: The Shanghai Municipal Food and Drug Administration (SMFDA) issued its 2017 Issue 7 Drug Supervision and Sampling Quality Announcement on November 24, 2017. This announcement detailed findings from quality supervision and sampling inspections conducted throughout 2017 on drug and pharmaceutical packaging material manufacturers, operators, and users in Shanghai. The inspections aimed to strengthen quality oversight, regulate market order, and ensure the safety of marketed drugs and packaging materials. The regulatory framework underpinning these inspections included the *Drug Administration Law of the People's Republic of China* and the 2015 Edition Chinese Pharmacopoeia. A total of 25 products from numerous companies, including Shanghai Huaying Pharmaceutical Co., Ltd., Shanghai Aikon Fine Chemical Co., Ltd., and various Traditional Chinese Medicine processing enterprises, were found to be non-compliant. Main violations spanned critical quality aspects such as incorrect properties, substandard processing, issues with content determination, presence of aflatoxin, residual solvent, and inappropriate moisture content. As a result, sampled units were required to immediately suspend sales and use of the affected products, initiate recalls, and implement rectification measures. The SMFDA committed to further strengthening follow-up inspections, urging local market supervision bureaus to enhance daily oversight, and compelling enterprises to investigate root causes, formulate corrective actions, and mitigate all potential risks.

Company: https://www.globalkeysolutions.net/companies/wujiang-shanghai-cai-tongde-traditional-chinese-medicine-pieces-co-ltd/44253fae-2704-457b-aece-d1783e4fa531/